Investigational Drug Information for Sulfatinib
✉ Email this page to a colleague
What is the drug development status for Sulfatinib?
Sulfatinib is an investigational drug.
There have been 19 clinical trials for Sulfatinib.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 7th 2015.
The most common disease conditions in clinical trials are Neuroendocrine Tumors, Neoplasms, and Carcinoid Tumor. The leading clinical trial sponsors are Hutchison Medipharma Limited, Fudan University, and BeiGene.
There are four US patents protecting this investigational drug and forty-six international patents.
Summary for Sulfatinib
| US Patents | 4 |
| International Patents | 46 |
| US Patent Applications | 18 |
| WIPO Patent Applications | 10 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 2 (2015-12-07) |
| Vendors | 44 |
Recent Clinical Trials for Sulfatinib
| Title | Sponsor | Phase |
|---|---|---|
| Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer | Fudan University | Phase 1/Phase 2 |
| Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer | Shanghai Zhongshan Hospital | Phase 1/Phase 2 |
| A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma | Chonnam National University | Phase 1/Phase 2 |
Clinical Trial Summary for Sulfatinib
Top disease conditions for Sulfatinib
Top clinical trial sponsors for Sulfatinib
US Patents for Sulfatinib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Sulfatinib | ⤷ Try a Trial | Stable, concentrated radionuclide complex solutions | ADVANCED ACCELERATOR APPLICATIONS (ITALY) S.R.L. (Pozzilli (Isernia), IT) | ⤷ Try a Trial |
| Sulfatinib | ⤷ Try a Trial | Stable, concentrated radionuclide complex solutions | ADVANCED ACCELERATOR APPLICATIONS (ITALY) S.R.L. (Pozzilli (Isernia), IT) | ⤷ Try a Trial |
| Sulfatinib | ⤷ Try a Trial | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use | Hutchison MediPharma Limited (Shanghai, CN) | ⤷ Try a Trial |
| Sulfatinib | ⤷ Try a Trial | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use | Hutchison Medipharma Limited (Shanghai, CN) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Sulfatinib
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Sulfatinib | Argentina | AR119655 | 2038-07-25 | ⤷ Try a Trial |
| Sulfatinib | Australia | AU2018433575 | 2038-07-25 | ⤷ Try a Trial |
| Sulfatinib | Australia | AU2022203683 | 2038-07-25 | ⤷ Try a Trial |
| Sulfatinib | Brazil | BR112021001148 | 2038-07-25 | ⤷ Try a Trial |
| Sulfatinib | Canada | CA3153630 | 2038-07-25 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
